Royalty Pharma PLC (RPRX) SEC Filings — 2025

Filings

• Royalty Pharma plc Files 8-K for Regulation FD Disclosure — 8-K · Dec 22, 2025
• Royalty Pharma's Q3 Net Income Dips Amid Soaring R&D, G&A Costs — 10-Q · Nov 5, 2025
• Royalty Pharma plc Files 8-K: Material Agreement & Financials — 8-K · Sep 16, 2025
• Royalty Pharma plc Files 8-K on Executive Changes — 8-K · Aug 13, 2025
• Royalty Pharma plc Files 8-K on Financials — 8-K · Aug 6, 2025
• Royalty Pharma's Q2 Royalties Surge 27% to $1.25B — 10-Q · Aug 6, 2025
• Royalty Pharma plc Files 8-K on Executive Changes and Financials — 8-K · Jul 17, 2025
• Royalty Pharma plc Files 8-K: Agreements, Acquisitions, and Executive Changes — 8-K · May 19, 2025
• Royalty Pharma plc Files 8-K on Security Holder Vote — 8-K · May 12, 2025
• Royalty Pharma plc Files 8-K for Operations Update — 8-K · May 8, 2025
• Royalty Pharma plc Files Q1 2025 10-Q — 10-Q · May 8, 2025
• Royalty Pharma plc Files 8-K — 8-K · Apr 11, 2025
• Royalty Pharma PLC Reports Director Changes and Compensation Updates — 8-K · Apr 10, 2025
• Royalty Pharma Files Preliminary Proxy for Deal — DEFA14A · Mar 5, 2025
• Royalty Pharma plc Files 2024 10-K — 10-K · Feb 12, 2025
• Royalty Pharma plc Files 8-K for Financial Reporting — 8-K · Feb 11, 2025
• Royalty Pharma Preps Proxy for Key Transaction — DEFA14A · Jan 17, 2025
• Royalty Pharma plc Files Proxy Statement for Proposed Transaction — DEFA14A · Jan 16, 2025
• Royalty Pharma plc Files Form 8-K — 8-K · Jan 13, 2025
• Royalty Pharma plc Files 8-K for Financial Reporting — 8-K · Jan 10, 2025
• Royalty Pharma plc (RPRX) Files 8-K — 8-K · Jan 10, 2025